MorphoSys AG buy knallfrosch44665
Summary
This prediction ended on 22.03.21 with a price of €77.16. With a performance of -5.02%, the BUY prediction for MorphoSys AG by knallfrosch44665 closed slightly in the red. knallfrosch44665 has a follow-up prediction for MorphoSys AG where he still thinks MorphoSys AG is a Buy. This prediction was marked as speculative and is excluded from knallfrosch44665's performance statistics.MorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
MorphoSys AG | - | - | - | - |
iShares Core DAX® | 3.523% | 3.763% | 26.705% | 22.165% |
iShares Nasdaq 100 | 1.026% | 2.380% | 29.587% | 39.491% |
iShares Nikkei 225® | -0.063% | 0.000% | 15.214% | 2.291% |
iShares S&P 500 | 0.557% | 2.222% | 27.662% | 40.483% |
Comments by knallfrosch44665 for this prediction
In the thread Morphosys AG diskutieren
In the thread Trading Morphosys AG